GlassScriptPhysician profile
Garry Lee Brady
NPI 1457513764
$5,620.36
in general payments reported to CMS, 2019-2025
48 companies · $436 in 2025
The $436 reported for 2025 was more than what 82% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $531 · 2021: $1,252 · 2022: $1,227 · 2023: $935 · 2024: $815 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128 · Education: $57.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.77 |
| Education | $57.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,552.07 | 2020-2025 | Linzess, Creon, Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $473.11 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $376.95 | 2021-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Lilly USA, LLC | $292.94 | 2019-2024 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $290.99 | 2021-2025 | Airsupra, Breztri, Evusheld |
| Novo Nordisk INC | $200.04 | 2020-2024 | Rybelsus, Ozempic |
| Electromed, INC. | $194.52 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $171.50 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $151.58 | 2019-2021 | |
| Mylan Specialty L.P. | $148.67 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $148.33 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $139.44 | 2022 | |
| Avanir Pharmaceuticals, INC. | $102.89 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $94.36 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $91.98 | 2021-2024 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garry Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.